News and articles : Page - 2

When a promising therapy like CAR-T doesn’t work, the emotional impact is hard – not just for patients, but also for the doctors who hoped it would work. Even in such aggressive cancers, though, CAR-T is not a surefire cure. So now what? Medical teams don’t see the CAR-T treatment as a dead end, but…

For decades, cancer treatment has followed a familiar path: chemotherapy, radiation, surgery – often in that order. But for patients with aggressive, treatment-resistant cancers, the outcome hasn’t changed much. That’s why a new frontier in T cells therapy is capturing the attention of both scientists and patients – and it’s called CAR T-cell therapy. More…

Prognosis has often been bleak for people with aggressive cancers no longer responding to standard therapeutic strategies. But a new generation of CAR-T therapy is rewriting that story, promising pinpoint hope where there was once only guesswork. This next-generation immunotherapy not only vanquishes cancer; it also trains IS to wage a more proficient and durable…

Deciding how to be treated for cancer is complex. It becomes even harder when choosing between a clinical trial and standard care, especially if treatment is sought abroad. The decision whether to enter a medical research study or choose proven standard care procedures can greatly affect the course a patient may take. Clinical trials can…

Concept of evolving stem cells in oncology fight is no longer futuristic – now it’s become an important arrow in the quiver in getting patients back on the mend after grueling treatments. These remarkable cells are known for their potential to grow into many different types of tissue. They are being used to help the…

Over recent years, gene editing has become a prime focus of discussion in cancer care. The buzz comes from CRISPR’s ability to help cancer doctors fight tumors by fixing genes. Rather than simply attacking cancer cells with traditional chemicals or radiation, these new techniques seek out the genetic faults at the very heart of tumor…

The immune system (IS) is essential to the body’s ability to recognize and protect against carcinomas. While they are the body’s own tissues, harmful cells are defective, and IS frequently the first defense against uncontrolled expansion. The relationship between anticancer response of an organism and tumor characteristics determines treatment efficacy and overall survival. Usually, cancer…

When it comes to serious blood cancers such as leukemia, lymphoma and multiple myeloma, the choice of hospital can make a big difference. Patients, beyond how effective a treatment is, frequently consider innovation and global expertise and specialists who will support them when choosing where to go. The best blood cancer hospitals today aren’t just…

For patients diagnosed with advanced or metastatic cancer, the treatment journey often shifts from curative to carefully managed care. But in recent years, the line between managing symptoms and actively targeting late stages cancer has begun to blur. With the rise of precision medicine, immunotherapies, and multidisciplinary care models, terminal cancer therapy is evolving –…

The future of oncology is no longer just chemotherapy, radiation or even immunotherapy. Today, the use of stem cell cancer therapy is becoming a new frontier in the war on cancers – not only to repair the harm done by the aggressive treatments, but also to directly attack the cancer cells by hitting them where…

Some cancers can have extremely encouraging outcomes these days, with early detection and a constant march of medical approaches to treatment. A cancer diagnosis is never good news, of course, but some cancers do particularly well when they are treated – so well, in fact, that they are often cured. Current health data points out…

Less than 5% of individuals with cancer take part in clinical trials today – but a growing number of worldwide initiatives aim to change that by broadening access as well as simplifying the application process. New tools, including the National Cancer Institute’s (NCI) searchable NCI database, are helping individuals locate open oncological protocols across United…